Patents by Inventor Bernard Scatton

Bernard Scatton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of ischemic disorders of the retina and optic nerve head
    Patent number: 6020352
    Abstract: The use of polyamine site antagonists in treating ischemic disorders of the retina and optic nerve head are disclosed. Especially preferred are certain 1-phenyl-2-piperidinoalkanol derivatives, such as eliprodil and ifenprodil.
    Type: Grant
    Filed: November 18, 1997
    Date of Patent: February 1, 2000
    Assignee: Synthelabo
    Inventors: Michael A. Kapin, Louis Desantis, Jr., Bernard Scatton, Salomon Langer
  • Method of preventing peripheral neuropathies induced by anticancer agents
    Patent number: 5652248
    Abstract: Eliprodil, or an enantiomer thereof, is indicated for combined administration with anticancer agents in order to prevent peripheral neuropathies induced by administration of the anticancer agents.
    Type: Grant
    Filed: October 24, 1994
    Date of Patent: July 29, 1997
    Assignee: Synthelabo
    Inventors: Delphine Lekieffre, Jesus Benavides, Bernard Scatton, Pascal George
  • Method of treatment of peripheral neuropathies and central neurodegenerative diseases
    Patent number: 5543421
    Abstract: Ifenprodil and its enantiomers are disclosed for the preparation of medicines useful for the treatment of peripheral neuropathies and chronic neurodegenerative diseases of the central nervous system.
    Type: Grant
    Filed: October 24, 1994
    Date of Patent: August 6, 1996
    Assignee: Synthelabo
    Inventors: J esus Benavides, Badia Ferzaz, Pascal George, Bernard Scatton